This site is intended for health professionals only

Published on 11 February 2009

Share this story:
Twitter
LinkedIn

Systagenix appoints president of Europe

teaser

Systagenix Wound Management, a new portfolio company, is expanding its senior team as it aims to become the leading wound care company, committed to providing innovative products, which enhance patient recovery.

The appointment of Frank DiLazzaro as President of Europe, Middle East & Africa (EMEA) will strengthen the European and global management teams. Frank’s remit is to make Systagenix Wound Management the number one choice for wound care products in EMEA.

He has an exceptional track record in wound care having played a significant role in the transformation of the negative pressure wound therapy business at Kinetic Concepts Inc.

Frank has worked in both public and private equity settings, and this wealth of experience coupled with his academic background in Economics will stand him in good stead as he starts to drive the dynamic vision set out by Systagenix to grow and build its internationally renowned advanced and general wound care product portfolios.

Steve Atkinson, CEO of Systagenix Wound Management, commenting on Frank’s appointment says: “I am delighted that Frank is joining our team and look forward to his success in driving the Systagenix business forward in these markets. Our aim is to be the strongest and most admired wound care company in the world and Frank, with his exceptional track record will be a key player in us achieving this objective.”

Frank DiLazzaro commented on his new appointment: “I am delighted to be joining Systagenix at this critical stage in leveraging the company’s profile and reputation to the highest level. There is a huge opportunity to grow the business, make Systagenix the leading force in innovative wound care solutions, which meet the demands and needs of our customers, to improve and transform the lives of patients. We have an impressive, advanced, diverse and unique product portfolio, and I am looking forward to building our position in the market place as we accelerate towards the number one wound care solution position.”

Systagenix



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn